TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04864860

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: brown seaweed (ecklonia cava)
Description: The intervention product used in this study is a dietary supplement called Seanol that contain 13% pholoratannic polyphenol per capsule as stated by the manufacture company (Seanol inside, 4215 95th St SW Lakewood, WA 98499 USA). Other ingredients are dextrin, magnesium stearate and silica (in neglected percentage). The intervention supplement is encapsulated in vegetable cellulose that contains 500 Ecklonia cava extract (Seanol). The placebo will be dextrin (BETA CYCLODEXTRIN, NF) ordered from a pharmaceutical company MEDISCA (https://www.medisca.co.uk/). Dextrin was selected to account for the similar complex carbohydrate content of the intervention supplement. Placebo will be encapsulated in vegetable cellulose capsules that is identical in size and coulure to the intervention capsules. The empty capsules will be ordered from MEDISCA and will be encapsulated in by SPIMACO ADDWAIEH (SFDA registered pharmaceutical company) (http://www.spimaco.com.sa/).
Study: NCT05167383

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VRH (Virtual Reality Hypnosis)
Description: Hypnosis is delivered as a standardized therapeutic intervention through virtual reality, using a digital sedation software (AQUA ®, Onfomfort SA).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard care
Description: The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.
Study: NCT06171308

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Traditional Chinese moxibustion apparatus
Description: The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine.~1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Chinese moxibustion apparatus
Description: The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine.~1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.
Study: NCT06029491

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RapidPulseTM Aspiration System
Description: The RapidPulseTM Aspiration System is designed to remove occlusive thrombus from the occluded cerebral vasculature using precisely pulsed aspiration. The system is comprised of the multi-use, non-sterile RapidPulseTM Aspiration Pump, the single use, sterile RapidPulseTM Tube set, the single use, non-sterile RapidPulseTM Collection Canister and the single use, sterile RapidPulseTM 071 Catheter.
Study: NCT05761184

Intervention type: DIAGNOSTIC_TEST
Intervention: Serum collection for proteomic analysis
Description: Serum collection for proteomic analysis

Intervention type: DIAGNOSTIC_TEST
Intervention: Serum collection for proteomic analysis
Description: Serum collection for proteomic analysis
Study: NCT05661968

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online educational program
Description: The intervention group will receive an online educational program, containing current information on low back pain management according to international clinical practice guidelines. Program content includes recommendations on assessment, diagnosis, and treatment of low back pain. The online program has 6 units of studies, with the content offered in the formats of video classes, infographics, texts, websites and clinical cases. The participant must complete the course within 6 weeks and will be able to set their own pace. Participants in the intervention group will receive their login and access password via email.
Study: NCT05795335

Intervention type: DRUG
Intervention: CDK4/6 inhibitor
Description: CDK4/6 inhibitors
Study: NCT06630325

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy
Study: NCT05486286

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NCKU-NG system
Description: A live-video system (NCKU-NG system) was developed to assist in the placement of enteral feeding tubes. This system consists of a camera and light source that can be inserted into the commercial NG tube to view live video during feeding tube placement. Manual air insufflation may aid feeding tube placement and improve visualization of anatomic landmarks. After the procedure, an abdominal X-ray is done to confirm the position of the feeding tube.
Study: NCT06260865

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MORA Cure
Description: MORA Cure (ETH-01K), developed by EverEx, Inc., is a digital therapeutics (S/W medical device) designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: In the control group, education is delivered and self-exercise is recommended.
Study: NCT05843383

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol
Description: Ciprofol group will be started and maintained total intravenous anesthesia with ciprofol and remifentanil

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol group will be started and maintained total intravenous anesthesia with propofol and remifentanil
Study: NCT06630325

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study: NCT05481320

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REACH VN Phone Intervention
Description: 4-6 intervention sessions delivered via phone over the course of 1-3 months.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Enhanced Control
Description: A single phone session providing education about dementia.
Study: NCT05287763

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Palatal soft tissue graft harvesting
Description: After local anaesthesia, a horizontal incision 2 mm apically from the gingival margin will be carried out using a #15C blade. The standardized rectangular graft with a thickness of 1.5 mm will be harvested from distal aspect of canine till first molar. The graft will be lifted and separated using tissue forceps and a blade till it is free from all sides.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Palatal soft tissue graft harvesting
Description: After local anaesthesia, a horizontal incision 2 mm apically from the gingival margin will be carried out using a #15C blade. The standardized rectangular graft with a thickness of 1.5 mm will be harvested from distal aspect of canine till first molar. The graft will be lifted and separated using tissue forceps and a blade till it is free from all sides.
Study: NCT05750394

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uterine layers closed
Description: Uterus closed with 1, 2 or 3 layers

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uterine layers closed
Description: Uterus closed with 1, 2 or 3 layers

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uterine layers closed
Description: Uterus closed with 1, 2 or 3 layers

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suture Type
Description: Barbed or smooth

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suture Type
Description: Barbed or smooth

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suture Type
Description: Barbed or smooth

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endometrium
Description: Included or excluded

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endometrium
Description: Included or excluded

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endometrium
Description: Included or excluded
Study: NCT04740632

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Nutritional Counseling by a multidisciplinary team
Description: Active diet therapy, instructions on reading labels, cross-contamination, allergen-free, foods recipes
Study: NCT05405881

Intervention type: OTHER
Group type: OTHER
Intervention: Proprioception measurement tool
Description: No intervention, as it is a psychometric properties study

Intervention type: OTHER
Group type: OTHER
Intervention: Proprioception measurement tool
Description: No intervention, as it is a psychometric properties study
Study: NCT04252001

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: YESS! game
Description: The YESS! game is a real-life game for smartphone or tablet in which the player has to solve a mystery. The adolescent plays an active role in the course of the story. This results in an interactive experience. During the game, the adolescent is challenged with regard to self-management and responsible behaviour in general life, with parallels to medical selfmanagement and responsible behaviour.~The adolescent has to decide at several different moments whether to take action or not, whether to accept help or not and whether to share (fictive) confidential information or not. Other aspects that are covered are 'taking responsibility' and 'being on time'. The choices the adolescent makes throughout the game are registered in a coded manner, for later analysis. The game is available in Dutch, English and Spanish.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Snake '97
Description: Snake '97 is a game for smartphone or tablet which is free and can be downloaded in the App Store. The game is a remake of the original snake on the mobile phone in 1997 in which the player moves the snake around and makes the snake 'consume food' (little dots) which causes the snake to grow longer. The goal is to make the snake as large as possible. The game has 12 difficulty levels.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transition-toolkit
Description: The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transition-toolkit
Description: The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transition-toolkit
Description: The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.
Study: NCT06225453

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized perioperative blood pressure management strategy
Description: In this group, perioperative mean arterial pressure and systolic blood pressure are maintained at no less than -20% of the baseline values of each patient.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional perioperative blood pressure management strategy
Description: In this group, perioperative mean arterial pressure and systolic blood pressure are maintained at ≥65 mmHg and ≥90 mmHg, respectively, in all patients.
Study: NCT04760626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin icodec
Description: Participants will receive subcutaneous (s.c.) injections of insulin icodec once weekly for 52 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine 100U/mL
Description: Participants will receive subcutaneous (s.c.) injections of insulin analogues once daily for 52 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Degludec
Description: Participants will receive subcutaneous (s.c.) injections of insulin analogues once daily for 52 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine 300U/mL
Description: Participants will receive subcutaneous (s.c.) injections of insulin analogues once daily for 52 weeks.
Study: NCT06476249

Intervention type: OTHER
Intervention: without
Description: without

Intervention type: OTHER
Intervention: without
Description: without
Study: NCT06630325

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study: NCT05869747

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood Donation
Description: Participants asked to donate whole blood at a donation facility from a list provided by the study.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Plasma Donation
Description: Participants asked to donate plasma at a donation facility from a list provided by the study.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Zone 2 Training
Description: Participants asked to work out in their custom Zone 2 heart range 4 times a week for 45 to 60 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Fasting
Description: Participants asked to engage in an intermittent fasting routine of a 16 hour fast followed by an 8 hour eating period at least 4 times a week.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Surveys
Description: Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.
Study: NCT05943704

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: beef broth
Description: It indicates if the child has allergy of Beef or not.
Study: NCT05494918

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JSKN003
Description: JSKN003 is to be administered via intravenous (IV) dose
Study: NCT06630325

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study: NCT04093076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INO-4500
Description: INO-4500 will be administered ID on Day 0 and Week 4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INO-4500
Description: INO-4500 will be administered ID on Day 0 and Week 4.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CELLECTRA™ 2000
Description: EP using the CELLECTRA™ 2000 device will be administered following ID drug administration.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CELLECTRA™ 2000
Description: EP using the CELLECTRA™ 2000 device will be administered following ID drug administration.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CELLECTRA™ 2000
Description: EP using the CELLECTRA™ 2000 device will be administered following ID drug administration.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CELLECTRA™ 2000
Description: EP using the CELLECTRA™ 2000 device will be administered following ID drug administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered ID on Day 0 and Week 4.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered ID on Day 0 and Week 4.
Study: NCT05370482

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal laser ablation
Description: MRI-guided focal laser ablation for prostate cancer
Study: NCT06111625

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: blinatumomab
Description: Blinatumomab was administered via a peripherally inserted central catheter (PICC) with an initial dosage of 8 μg/day. The dosage gradually escalated to 28 μg/day, with a total dose of 175 μg, infused over 5 to 10 days. To mitigate the risk of cytokine release syndrome (CRS), dexamethasone at a dose of 20 mg was administered 12 hours before the onset of blinatumomab infusion.
Study: NCT05876832

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XY0206
Description: Dosage form:Tablet;Multiple dose phase:Take the medicine once a day,37.5mg at a time.4 weeks of continuous medication is one course of treatment. After the first course of treatment, the subjects can continue to receive the experimental drug treatment until the subjects meet the withdrawal criteria.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Salvage Chemotherapy
Description: Low-dose Cytarabine (LoDAC) or azacitidine, fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG) or mitoxantrone, etoposide, cytarabine (MEC)will be administered by subcutaneous (SC) and/or intravenous (IV) injections.